Novozymes A/S (CPH:NSIS.B)
378.00
-2.60 (-0.68%)
At close: Apr 28, 2026
Novozymes Revenue
In the year 2025, Novozymes had annual revenue of 4.16B EUR with 8.45% growth. Novozymes had revenue of 996.60M in the quarter ending December 31, 2025, with 1.55% growth.
Revenue
4.16B EUR
Revenue Growth
+8.45%
P/S Ratio
5.67
Revenue / Employee
369.14K EUR
Employees
11,263
Market Cap
176.12B DKK
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.16B | 324.10M | 8.45% |
| Dec 31, 2024 | 3.83B | 1.43B | 59.58% |
| Dec 31, 2023 | 2.40B | 42.38M | 1.80% |
| Dec 31, 2022 | 2.36B | 348.99M | 17.36% |
| Dec 31, 2021 | 2.01B | 128.32M | 6.82% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vestas Wind Systems | 140.57B |
| A.P. Møller - Mærsk | 343.41B |
| Ørsted | 73.24B |
| Danske Bank | 56.55B |
| Carlsberg | 89.10B |
| Genmab | 23.66B |
| Coloplast | 27.89B |
| Tryg A/S | 43.23B |
Novozymes News
- 2 months ago - Novozymes Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - Novozymes Earnings Call Transcript: Q3 2025 - Transcripts
- 8 months ago - Novozymes Earnings Call Transcript: Q2 2025 - Transcripts
- 1 year ago - Novozymes Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - Novozymes Transcript: AGM 2025 - Transcripts
- 1 year ago - Novozymes Earnings Call Transcript: Q4 2024 - Transcripts
- 1 year ago - Novozymes Transcript: M&A Announcement - Transcripts
- 1 year ago - Novozymes Transcript: Status Update - Transcripts